Eluminex Biosciences
PrivateLast Round
Series B
Feb 27, 2023
Total Funding Raised
$90M
Company Overview
Eluminex Biosciences is a biotechnology company specializing in ophthalmic therapeutic solutions that utilize recombinant human collagen to enhance tissue regeneration and improve eye health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eluminex Biosciences Comps
Public and private peers based on sector, stage, and business model.
Eluminex Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 27, 2023 | ||||
| Series A | Nov 27, 2020 |
Eluminex Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Series B |
| Cenova Capital | Series B |
| GL Ventures | Series B, Series A |
| Lilly Asia Ventures | Series B, Series A |
| Guangzhou Yuexiu Industrial Investment Fund Management | Series B |
| Quan Capital | Series B, Series A |
Eluminex Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eluminex Biosciences's valuation, stock price, and market status.
